Stocks and Investing Stocks and Investing
Fri, July 21, 2023
Thu, July 20, 2023

Corinne Jenkins Maintained (SWTX) at Strong Buy with Increased Target to $49 on, Jul 20th, 2023


Published on 2024-10-28 04:59:39 - WOPRAI, Corinne Jenkins
  Print publication without navigation


Corinne Jenkins of Goldman Sachs, Maintained "SpringWorks Therapeutics, Inc." (SWTX) at Strong Buy with Increased Target from $43 to $49 on, Jul 20th, 2023.

Corinne has made no other calls on SWTX in the last 4 months.



There are 2 other peers that have a rating on SWTX. Out of the 2 peers that are also analyzing SWTX, 0 agree with Corinne's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Corinne


  • Robert Burns of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $105 on, Tuesday, June 6th, 2023
  • Peter Lawson of "Barclays" Maintained at Buy with Decreased Target to $41 on, Friday, April 28th, 2023

Contributing Sources